All News

If you're waffling on the idea of taking out professional liability insurance, read this and think again.

Without provider status, it can take years for a pharmacist to achieve a good relationship with a medical practice.

Pharmacists must walk a careful line in the practice of ambulatory care pharmacy. Here are some things to think about.

MTM reimbursement gets a big push from the feds.

A recent ISMP study found that the government’s adverse event reporting system is hampered by incomplete reports from manufacturers.

From program launch through December 2014, CVS has sold 63% more smoking cessation products and seen 61% more Minute Clinic visits than it did during the same period a year earlier.

The country is moving toward provider status. But direct reimbursement isn't here yet.

Validation through inclusion in Medicare Part B could lead to recognition of pharmacists as healthcare providers across the board.

When consumers have to pay for their own healthcare, their first stop will be the corner drugstore. Get ready.

Ceftolozane/tazobactam was approved to treat complicated urinary tract infections and to treat - in combination with metronidazole - complicated intra-abdominal infections.

Pharmacists need to own this service. The survival of the profession may depend on it.

The nation's governors get it and have affirmed it publicly. When will the rest of the country get on board?

New study finds that AF patients under 65 years of age but with a CHA2DS2-VASc score of 1 are unlikely to benefit from anticoagulation therapy.

Time to give those babies some love.

New Rx, new generics, new OTC, new devices

Letters, e-mails, posts, and comments from Drug Topics readers

If you're Dennis Miller, the answer is a dozen more questions, and some of them are doozies.

A New Mexico state legislative committee has added a provision to an antiabortion measure that would allow pharmacists the right to not dispense abortion medication based on personal and religious beliefs.

West Virginia Supreme Court justices are debating a variation of that question involving doctors who negligently prescribed painkillers and some of the pharmacies that filled the scripts.

A federal judge recently denied Ranbaxy Laboratories Ltd's attempt to be the first drugmaker to launch generic versions of Nexium and Valcyte.

A national survey of pharmacy professionals released March 3 found that Genentech's decision to move three primary cancer drugs to specialty drug distribution has resulted in higher costs to hospitals and reduced availability of the medications.

To discourage the spread of infection, FDA has ordered manufacturers of multi-dose insulin pens to display the warning “For single patient use only” on all materials connected with the products.

Bob Benton's life in pharmacy has brought him satisfaction and enjoyment of his profession. And he's done a lot of people a lot of good.

A month after New York ordered Target, Walmart, Walgreens, and GNC to stop selling herbal supplements that routinely did not contain the ingredients advertised, one of the giant retailers has been hit with a class action lawsuit.

Louisiana State University’s (LSU) Health Sciences Center-New Orleans is partnering with CVS and Walgreens to expand its primary care reach.

FDA has sent a warning letter to a Portland-area compounding pharmacy listing six violations, including sterile practices.

The State Assembly and Senate have approved legislation to delay mandatory electronic prescribing of controlled substances in New York for one year.

In an effort to curb prescription drug abuse, at least one state has embraced the concept of limiting some people to a specific prescriber and pharmacy for controlled substances. And the concept is also gaining some traction nationally.